DCN Dx acquires Biomed Diagnostics

LabPulse.com staff writers
Apr 24, 2022
2020 02 21 19 47 4640 Lab Petri Microbiology 400

Point-of-care (POC) diagnostics company DCN Dx has acquired microbiological testing products firm Biomed Diagnostics.

The purchase expands DCN Dx's reach into the point-of-use testing and sampling market by adding a number of tests to its portfolio, including InPouch TV for detection of Trichomonas vaginalis, Transport Media (VTM) for SARS-CoV-2 sample transport, and InTray VS COLOREX for testing for methicillin-resistant Staphylococcus aureus (MRSA).

Latest in Staphylococcus
2020 07 09 20 19 5888 Data Analytics Charts 400
Labcorp launches smart laboratory test reports
July 8, 2020
The 60-second TB test | Tallying costs, benefits of NIPT upfront | More to the BPA exposure story
December 9, 2019
2019 05 13 20 10 9004 Staphylococcus Aureus Bacteria 400
ATS, IDSA revamp pneumonia testing guidance
October 2, 2019
2019 04 30 22 11 5866 Bacteria 400
Coated, folded paper creates mobile lab for field tests
August 20, 2019
Related Stories
2020 07 02 23 31 0378 Handshake Meeting 400
Collaboration
Point-of-care developer DCN Dx acquires IVD Vision
2020 10 14 15 59 9456 Business Woman Handshake 400
Collaboration
DCN Dx acquires PortaScience
2020 07 09 20 19 5888 Data Analytics Charts 400
Staphylococcus
Labcorp launches smart laboratory test reports
More in Staphylococcus
Labcorp launches smart laboratory test reports
The reports are available for diseases that have significant health risks on their own or as co-morbidities for other conditions, such as diabetes and chronic kidney disease. Labcorp has also created reports for conditions that impact hospitalizations, such as community-acquired methicillin-resistant Staphylococcus aureus (MRSA).
July 8, 2020
2020 07 09 20 19 5888 Data Analytics Charts 400
The 60-second TB test | Tallying costs, benefits of NIPT upfront | More to the BPA exposure story
Dear LabPulse Member,
December 9, 2019
ATS, IDSA revamp pneumonia testing guidance
The new recommendations apply to the diagnosis and treatment of community-acquired pneumonia, from the time of signs and symptoms through treatment with antibiotics and follow-up chest imaging. They were published by a multidisciplinary team, including Dr. Joshua Metlay, PhD, chief of internal medicine at Massachusetts General Hospital (American Journal of Respiratory and Critical Care Medicine, October 1, 2019, Vol. 200:7, pp. e45-e65).
October 2, 2019
2019 05 13 20 10 9004 Staphylococcus Aureus Bacteria 400
Coated, folded paper creates mobile lab for field tests
The coated paper worked significantly more efficiently and reliably than any type of dry, uncoated paper when testing biological materials in the field -- for example, for use following a natural disaster, wrote Daniel Regan, a research and development engineer at the University of Maine, and colleagues in the journal, a publication of the American Institute of Physics.
August 20, 2019
2019 04 30 22 11 5866 Bacteria 400
iCubate's iC-GN Gram-negative assay clears FDA
Bacteria picked up by the iC-GN test include Acinetobacter baumannii complex, Escherichia coli, and Klebsiella pneumoniae, while the antibiotic resistance markers screened by the test include K. pneumoniae carbapenemase (KPC) and New Delhi metallo-beta-lactamase (NDM). Testing takes from two to three minutes, with results available in from 3 to 4.5 hours, according to the company.
July 14, 2019
2019 07 15 17 19 4107 Bacteria Blood Sepsis 400
T2Bacteria panel proves itself, but will hospitals buy in?
The prospective study of 1,427 patients in 11 centers tested the sensitivity, specificity, and speed of the T2Bacteria panel, which is an insert for T2 Biosystems' T2Dx miniaturized magnetic resonance instrument. The system directly tests blood for five types of bacteria ("ESKAPE pathogens") that cause bloodstream infections (BSI): Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli.
May 13, 2019
2019 05 13 20 10 9004 Staphylococcus Aureus Bacteria 400
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Page 1 of 1